Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The Food and Drug Administration on July 3 granted expanded use of a cooling cap designed to limit hair loss in chemotherapy patients.
The Food and Drug Administration on June 30 approved Triptodur to treat children with central precocious puberty.
Low market competition levels are strongly associated with increases in generic drug prices, according to a study published in Annals of Internal Medicine.
Nearly 118,000 people in the U.S. are waiting for organ transplants, and an estimated 8,000 of them will not live long enough to receive a transplant, according to STAT.
Last week, the Clarify Health team and I attended the 7th Annual National Bundled Payments Summit. The conference covered a range of topics including what changes to expect from episode payment models, the challenges and opportunities bundled payments present to…
Jean Drouin, MD, MBA â CEO and co-founder of Clarify Health Solutions
We’ve all seen the headlines: Hospital systems laying people off, cutting services, shutting their doors. This heightened desperation in healthcare is mainly driven by shrinking reimbursements.
Chris Gormley, CEO, Medpricer
Vertex Pharmaceutical increased the price of its cystic fibrosis drug Orkambi for the first time since the drug's 2015 approval, reports Boston Business Journal.
Novo Nordisk voluntarily recalled five batches of insulin cartridge holders used in some of its NovoPen Echo devices over quality issues.
The Food and Drug Administration on Wednesday placed a clinical hold on three of Merck's multiple myeloma clinical trials following numerous reports of patient deaths, reports Reuters.
The British government hopes to collaborate with the European Union on drug regulation post-Brexit, reports Reuters.